Increased Risk of Systemic Lupus Erythematosus in Patients with Chronic Urticaria: A Systematic Review and Meta-analysis.
association
autoimmune diseases
chronic urticaria
meta-analysis
systemic lupus erythematosus
Journal
Mediterranean journal of rheumatology
ISSN: 2529-198X
Titre abrégé: Mediterr J Rheumatol
Pays: Greece
ID NLM: 101730166
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
14
01
2023
revised:
28
02
2023
accepted:
01
03
2023
medline:
1
9
2023
pubmed:
1
9
2023
entrez:
1
9
2023
Statut:
epublish
Résumé
The association between systemic lupus erythematosus (SLE) and chronic urticaria (CU) has been suggested in the literature although the amount of evidence is still relatively limited. We aimed to combine all available studies on this association using systematic review and meta-analysis technique. Potentially eligible studies were identified from Medline and EMBASE from inception to February 2023 using search strategy that comprised of terms for "chronic urticaria" and "systemic lupus erythematosus". The eligible study must consist of one group of patients with CU and another group of comparators without CU and must compare the prevalence of SLE in each group and report effect size with 95% confidence intervals (95% CIs). We extracted such data from each study to calculate a pooled odds ratio using the generic inverse variance method with random-effect model. Funnel plot was used to evaluate publication bias. Newcastle-Ottawa Scale was used to appraise the methodological quality of the included studies. A total of 5,155 articles were identified. After two rounds of independent review by four investigators, five studies met the eligibility criteria and were included in the meta-analysis. The meta-analysis found an increased prevalence of SLE among patients with CU compared with individuals without CU with the pooled odds ratio of 5.03 (95% CI, 2.57-9.85, I2 of 93%). This systematic review and meta-analysis found that patients with CU had a significantly increased risk of SLE compared to individuals without CU.
Identifiants
pubmed: 37654642
doi: 10.31138/mjr.34.2.121
pii: MJR-34-2-121
pmc: PMC10466354
doi:
Types de publication
Journal Article
Langues
eng
Pagination
121-128Informations de copyright
© 2023 The Mediterranean Journal of Rheumatology (MJR).
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare. All co-authors have seen and agree with the contents of the manuscript and there is no financial interest to report.
Références
Front Med (Lausanne). 2021 Feb 10;7:598665
pubmed: 33644084
Yonsei Med J. 2004 Jun 30;45(3):392-5
pubmed: 15227724
Expert Rev Clin Immunol. 2017 Aug;13(8):799-814
pubmed: 28471259
Gut Microbes. 2013 Nov-Dec;4(6):505-31
pubmed: 23962822
J Allergy Clin Immunol. 2012 May;129(5):1307-13
pubmed: 22336078
J Clin Invest. 2004 Sep;114(5):616-9
pubmed: 15343378
J Dermatol. 2018 Jan;45(1):10-16
pubmed: 28983950
Eur Ann Allergy Clin Immunol. 2022 May;54(3):123-130
pubmed: 33939347
Pediatr Allergy Immunol. 2018 Nov;29(7):732-739
pubmed: 30054929
World Allergy Organ J. 2020 Jan 25;13(1):100097
pubmed: 32021661
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Lupus. 2014 May;23(6):518-26
pubmed: 24763536
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Nat Rev Dis Primers. 2022 Sep 15;8(1):61
pubmed: 36109590
Gut Pathog. 2016 Dec 8;8:64
pubmed: 27980687
Indian J Dermatol. 2009;54(2):132-6
pubmed: 20101308
Br J Dermatol. 1999 May;140(5):853-8
pubmed: 10354022
Int J Dermatol. 2022 Aug;61(8):988-994
pubmed: 35100439
Lupus. 2010 Sep;19(10):1187-94
pubmed: 20501526
Front Immunol. 2022 Feb 10;13:833424
pubmed: 35222423
J Clin Pathol. 2003 Jul;56(7):481-90
pubmed: 12835292
Int J Dermatol. 2018 Jul;57(7):822-829
pubmed: 29663342
Front Pharmacol. 2021 Nov 23;12:759095
pubmed: 34887760
Appl Environ Microbiol. 2014 Dec;80(24):7551-60
pubmed: 25261516
J Dermatol. 2019 Jan;46(1):26-32
pubmed: 30368876
Pediatr Allergy Immunol. 2022 Feb;33(2):e13736
pubmed: 35212038
Int Arch Allergy Immunol. 2010;153(4):419-23
pubmed: 20559009
Allergy Asthma Immunol Res. 2017 Nov;9(6):477-482
pubmed: 28913986